Volume | 907,710 |
|
|||||
News | (2) | ||||||
Day High | 0.4095 | Low High |
|||||
Day Low | 0.3507 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Virios Therapeutics Inc | VIRI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.4095 | 0.3507 | 0.4095 | 0.3514 | 0.386 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
878 | 907,710 | $ 0.3680598 | $ 334,092 | - | 0.279 - 2.42 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:26 | formt | 770 | $ 0.2328 | USD |
Virios Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.74M | 19.26M | - | 0 | -5.3M | -0.28 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Virios Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VIRI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.367 | 0.4366 | 0.335 | 0.3762913 | 138,730 | -0.1342 | -36.57% |
1 Month | 0.459 | 0.4749 | 0.335 | 0.4028903 | 108,392 | -0.2262 | -49.28% |
3 Months | 0.3886 | 0.6288 | 0.279 | 0.4331042 | 305,567 | -0.1558 | -40.09% |
6 Months | 0.721 | 0.94 | 0.279 | 0.4844292 | 267,897 | -0.4882 | -67.71% |
1 Year | 1.03 | 2.42 | 0.279 | 1.07 | 458,866 | -0.7972 | -77.40% |
3 Years | 4.70 | 9.1109 | 0.218951 | 1.08 | 493,824 | -4.47 | -95.05% |
5 Years | 13.76 | 14.39 | 0.218951 | 1.58 | 466,057 | -13.53 | -98.31% |
Virios Therapeutics Description
Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia. |